<DOC>
	<DOC>NCT01531920</DOC>
	<brief_summary>A Phase 1 study in healthy subjects to determine the safety, tolerability, psychomotor function, and cognitive effects of perampanel when administered alone and with alcohol.</brief_summary>
	<brief_title>A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel</brief_title>
	<detailed_description />
	<mesh_term>Ethanol</mesh_term>
	<criteria>Inclusion: Healthy male and female subjects Females agreed to use two medically acceptable methods of contraception, unless they were surgically sterile Aged 1855 yrs, inclusive Achieved a Continuous Tracking Test (CTT )score increase of &gt;1.5 pixels from prealcohol when dosed with alcohol during the Screening Period (Day minus 8 plus/minus 2 days) Had a current driving license and drove regularly (e.g., more than 1000 miles a year (Part B only) Exclusion: Any history of significant alcohol abuse or psychiatric disease, requiring inpatient admission or prolonged treatment with psychotropic medication Unable to follow the instructions for the psychometric testing Intolerant to the driving simulator (Part B only) Unable to adhere to long periods of confinement (subjects who could not follow the instructions of the protocol, including the meals) Use of prescription drugs or overthecounter (OTC) medications within 2 weeks prior to Screening (unless drug had a long half life [i.e., 5 x t 1/2&gt;2 weeks]) with the exception of paracetamol (up to 4 g/day), which was allowed up to 12 hours prior to dosing Had taken any inhibitor of CYP450 within 2 weeks prior to the first dosing (e.g., grapefruit, grapefruit juice, grapefruitcontaining beverages, or Seville orange products) Had taken St John's Wort or other dietary aids known to induce CYP3A4 within 4 weeks prior to dosing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>